Resolution
|
Votes for
|
% of votes cast
|
Votes against
|
% of votes cast
|
Votes cast in total
|
Total votes cast as a % of issued share capital
|
Votes withheld
| |
1
|
To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2020
|
951,285,688
|
99.86
|
1,300,153
|
0.14
|
952,585,841
|
72.56
|
8,944,126
|
2
|
To confirm dividends
|
948,459,461
|
98.72
|
12,290,505
|
1.28
|
960,749,966
|
73.19
|
779,685
|
3
|
To reappoint PricewaterhouseCoopers LLP as Auditor
|
952,398,382
|
99.15
|
8,210,440
|
0.85
|
960,608,822
|
73.17
|
921,116
|
4
|
To authorise the Directors to agree the remuneration of the Auditor
|
959,859,984
|
99.93
|
712,232
|
0.07
|
960,572,216
|
73.17
|
956,959
|
5a
|
To re-elect Leif Johansson as a Director
|
927,811,941
|
96.57
|
32,966,929
|
3.43
|
960,778,870
|
73.19
|
750,714
|
5b
|
To re-elect Pascal Soriot as a Director
|
959,330,670
|
99.85
|
1,441,425
|
0.15
|
960,772,095
|
73.19
|
757,539
|
5c
|
To re-elect Marc Dunoyer as a Director
|
955,828,852
|
99.52
|
4,600,836
|
0.48
|
960,429,688
|
73.16
|
1,099,897
|
5d
|
To re-elect Philip Broadley as a Director
|
948,284,819
|
98.74
|
12,063,553
|
1.26
|
960,348,372
|
73.15
|
1,160,972
|
5e
|
To elect Euan Ashley as a Director
|
952,998,109
|
99.28
|
6,906,560
|
0.72
|
959,904,669
|
73.12
|
1,623,921
|
5f
|
To re-electMichel Demaré as a Director
|
940,774,376
|
97.96
|
19,589,264
|
2.04
|
960,363,640
|
73.16
|
1,165,704
|
5g
|
To re-elect Deborah DiSanzo as a Director
|
826,293,184
|
86.04
|
134,102,115
|
13.96
|
960,395,299
|
73.16
|
1,140,585
|
5h
|
To elect Diana Layfield as a Director
|
959,699,058
|
99.93
|
675,091
|
0.07
|
960,374,149
|
73.16
|
1,154,886
|
5i
|
To re-elect Sheri McCoy as a Director
|
710,781,431
|
74.03
|
249,365,290
|
25.97
|
960,146,721
|
73.14
|
1,388,375
|
5j
|
To re-elect Tony Mok as a Director
|
958,732,518
|
99.83
|
1,606,337
|
0.17
|
960,338,855
|
73.15
|
1,184,730
|
5k
|
To re-elect Nazneen Rahman as a Director
|
950,350,073
|
99.73
|
2,544,392
|
0.27
|
952,894,465
|
72.59
|
8,634,879
|
5l
|
To re-elect Marcus Wallenberg as a Director
|
828,248,091
|
86.21
|
132,435,623
|
13.79
|
960,683,714
|
73.18
|
832,550
|
6
|
To approve the Annual Report on Remuneration for the year ended 31 December 2020
|
915,909,189
|
95.42
|
43,957,696
|
4.58
|
959,866,885
|
73.12
|
1,662,608
|
7
|
To approve the Directors' Remuneration Policy
|
564,935,789
|
60.19
|
373,708,277
|
39.81
|
938,644,066
|
71.50
|
21,415,088
|
8
|
To authorise limited political donations
|
930,305,254
|
96.90
|
29,777,151
|
3.10
|
960,082,405
|
73.13
|
1,446,855
|
9
|
To authorise the Directors to allot shares
|
817,312,076
|
85.14
|
142,701,485
|
14.86
|
960,013,561
|
73.13
|
1,515,509
|
10
|
To authorise the Directors to disapply pre-emption rights
|
939,179,092
|
98.03
|
18,824,969
|
1.97
|
958,004,061
|
72.98
|
3,474,403
|
11
|
To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments
|
932,779,470
|
97.36
|
25,292,148
|
2.64
|
958,071,618
|
72.98
|
3,406,846
|
12
|
To authorise the Company to purchase its own shares
|
942,491,633
|
98.16
|
17,676,115
|
1.84
|
960,167,748
|
73.14
|
1,310,466
|
13
|
To reduce the notice period for general meetings
|
847,834,118
|
88.31
|
112,182,050
|
11.69
|
960,016,168
|
73.13
|
1,462,280
|
14
|
To amend the rules of the 2020 Performance Share Plan
|
579,132,133
|
61.72
|
359,154,356
|
38.28
|
938,286,489
|
71.47
|
21,721,411
|
Attachments
- Original document
- Permalink
Disclaimer
AstraZeneca plc published this content on 11 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 May 2021 14:09:09 UTC.